Showing results (61-70 of 92) with videos related to
Sort By:
Pageof 10
Journal of Medicinal Chemistry|July 1, 1987
C3-methylated 5-hydroxy-2-(dipropylamino)tetralins: conformational and steric parameters of importance for central dopamine receptor activationA M Johansson, J L Nilsson, A Karlén, et al.The Journal of Pharmacology and Experimental Therapeutics|July 1, 1991
Pharmacology of the novel 5-hydroxytryptamine1A receptor antagonist (S)-5-fluoro-8-hydroxy-2-(dipropylamino)tetralin: inhibition of (R)-8-hydroxy-2-(dipropylamino)tetralin-induced effectsL Björk, L J Cornfield, D L Nelson, et al.Journal of Chemical Information and Computer Sciences|July 1, 1997
Molecular design using the minireceptor conceptJ M Jansen, K F Koehler, M H Hedberg, et al.Journal of Medicinal Chemistry|October 1, 1989
(R)- and (S)-5,6,7,8-tetrahydro-1-hydroxy-N,N-dipropyl-9H-benzocyclohepten- 8-ylamine. Stereoselective interactions with 5-HT1A receptors in the brainY Liu, C Mellin, L Björk, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|May 1, 1996
The 5-HT1A receptor antagonist (S)-UH-301 augments the increase in extracellular concentrations of 5-HT in the frontal cortex produced by both acute and chronic treatment with citalopramL Arborelius, G G Nomikos, P Hertel, et al.Journal of Medicinal Chemistry|December 1, 1981
3-Phenylpiperidines. Central dopamine-autoreceptor stimulating activityU Hacksell, L E Arvidsson, U Svensson, et al.Journal of Medicinal Chemistry|August 1, 1984
C1-Methylated 5-hydroxy-2-(dipropylamino)tetralins: central dopamine-receptor stimulating activityU Hacksell, A M Johansson, L Arvidsson, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|April 1, 1993
The 5-HT1A receptor selective ligands, (R)-8-OH-DPAT and (S)-UH-301, differentially affect the activity of midbrain dopamine neuronsL Arborelius, K Chergui, S Murase, et al.Journal of Medicinal Chemistry|June 1, 1988
Central dopaminergic and 5-hydroxytryptaminergic effects of C3-methylated derivatives of 8-hydroxy-2-(di-n-propylamino)tetralinC Mellin, L Björk, A Karlén, et al.Journal of Medicinal Chemistry|August 1, 1982
Monophenolic octahydrobenzo[f]quinolines: central dopamine- and serotonin-receptor stimulating activityH Wikström, D Sanchez, P Lindberg, et al.Pageof 10